Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -20,284 | -8,667 | -35,443 |
| Depreciation Amortization | -229 | -324 | 59 |
| Accounts payable and accrued liabilities | 40 | -9 | N/A |
| Other Working Capital | 659 | 373 | 4,439 |
| Other Operating Activity | 1,042 | 641 | 1,141 |
| Operating Cash Flow | $-18,772 | $-7,986 | $-29,804 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 24,664 | -78,699 | N/A |
| PPE Investments | -6 | N/A | -14 |
| Other Investing Activity | 0 | 0 | -55,338 |
| Investing Cash Flow | $24,658 | $-78,699 | $-55,352 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -16,223 | -833 | N/A |
| Common Stock Issued | 233 | 68 | N/A |
| Other Financing Activity | 0 | 0 | 119,692 |
| Financing Cash Flow | $-15,990 | $-765 | $119,692 |
| Beginning Cash Position | 88,143 | 88,143 | 53,607 |
| End Cash Position | 78,039 | 693 | 88,143 |
| Net Cash Flow | $-10,104 | $-87,450 | $34,536 |
| Free Cash Flow | |||
| Operating Cash Flow | -18,772 | -7,986 | -29,804 |
| Capital Expenditure | -6 | N/A | N/A |
| Free Cash Flow | -18,778 | -7,986 | -29,804 |